• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部乳腺癌手术后的放射治疗:经典预后因素和近似遗传亚型的预后预测。

Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes.

机构信息

Department of Diagnostic Imaging and Radiation Oncology, Federico II University School of Medicine, via S. Pansini 5, 80131, Naples, Italy.

出版信息

J Radiat Res. 2013 Mar 1;54(2):292-8. doi: 10.1093/jrr/rrs087. Epub 2012 Sep 26.

DOI:10.1093/jrr/rrs087
PMID:23019151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3589925/
Abstract

The purpose of this study was to evaluate the outcome prediction power of classical prognostic factors along with surrogate approximation of genetic signatures (AGS) subtypes in patients affected by localized breast cancer (BC) and treated with postoperative radiotherapy. We retrospectively analyzed 468 consecutive female patients affected by localized BC with complete immunohistochemical and pathological information available. All patients underwent surgery plus radiotherapy. Median follow-up was 59 months (range, 6-132) from the diagnosis. Disease recurrences (DR), local and/or distant, and contralateral breast cancer (CBC) were registered and analyzed in relation to subtypes (luminal A, luminal B, HER-2, and basal), and classical prognostic factors (PFs), namely age, nodal status (N), tumor classification (T), grading (G), estrogen receptors (ER), progesterone receptors and erb-B2 status. Bootstrap technique for variable selection and bootstrap resampling to test selection stability were used. Regarding AGS subtypes, HER-2 and basal were more likely to recur than luminal A and B subtypes, while patients in the basal group were more likely to have CBC. However, considering PFs along with AGS subtypes, the optimal multivariable predictive model for DR consisted of age, T, N, G and ER. A single-variable model including basal subtype resulted again as the optimal predictive model for CBC. In patients bearing localized BC the combination of classical clinical variables age, T, N, G and ER was still confirmed to be the best predictor of DR, while the basal subtype was demonstrated to be significantly and exclusively correlated with CBC.

摘要

本研究旨在评估经典预后因素以及替代近似遗传特征(AGS)亚型在接受术后放疗的局限性乳腺癌(BC)患者中的预后预测能力。我们回顾性分析了 468 例接受手术加放疗的局限性 BC 女性患者。所有患者均接受了手术加放疗。从诊断到中位随访时间为 59 个月(范围为 6-132)。登记并分析了局部和/或远处疾病复发(DR)、对侧乳腺癌(CBC)与亚型(luminal A、luminal B、HER-2 和基底)和经典预后因素(PFs)的关系,包括年龄、淋巴结状态(N)、肿瘤分类(T)、分级(G)、雌激素受体(ER)、孕激素受体和 erb-B2 状态。采用变量选择的 Bootstrap 技术和 Bootstrap 重采样来测试选择稳定性。关于 AGS 亚型,HER-2 和基底型比 luminal A 和 B 型更容易复发,而基底型患者更有可能发生 CBC。然而,考虑到 PFs 和 AGS 亚型,DR 的最佳多变量预测模型包括年龄、T、N、G 和 ER。单一变量模型包括基底亚型再次成为 CBC 的最佳预测模型。在患有局限性 BC 的患者中,经典临床变量年龄、T、N、G 和 ER 的组合仍然被证实是 DR 的最佳预测因子,而基底亚型与 CBC 显著且独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a54/3589925/d4572edf3a33/rrs08702.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a54/3589925/96af0237c132/rrs08701.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a54/3589925/d4572edf3a33/rrs08702.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a54/3589925/96af0237c132/rrs08701.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a54/3589925/d4572edf3a33/rrs08702.jpg

相似文献

1
Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes.局部乳腺癌手术后的放射治疗:经典预后因素和近似遗传亚型的预后预测。
J Radiat Res. 2013 Mar 1;54(2):292-8. doi: 10.1093/jrr/rrs087. Epub 2012 Sep 26.
2
Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.保乳治疗早期乳腺癌中乳腺癌亚型对乳腺癌特异性生存、远处转移和局部复发率的预后价值:一项回顾性临床研究。
Eur J Surg Oncol. 2011 Oct;37(10):876-82. doi: 10.1016/j.ejso.2011.07.001. Epub 2011 Aug 6.
3
[Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].[不同分子亚型可手术乳腺癌患者的临床特征与生存情况]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51.
4
Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.保乳手术后最大直径小于或等于 2cm 的乳腺癌免疫组化定义亚型的长期预后
J Surg Res. 2019 Apr;236:288-299. doi: 10.1016/j.jss.2018.11.028. Epub 2018 Dec 27.
5
[Clinical features and prognosis analysis of different breast cancer molecular subtypes].不同乳腺癌分子亚型的临床特征及预后分析
Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):42-6.
6
Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.早期乳腺癌乳房切除术后的大分割放射治疗:克赖斯特彻奇的经验。
J Med Imaging Radiat Oncol. 2015 Apr;59(2):243-7. doi: 10.1111/1754-9485.12242. Epub 2014 Oct 6.
7
Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?行保乳术治疗的 pT1-2N0 乳腺癌女性,生物学亚型是否与局部区域复发风险相关?
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):57-64. doi: 10.1016/j.ijrobp.2013.09.024. Epub 2013 Oct 22.
8
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.通过雌激素受体、孕激素受体和人表皮生长因子受体2来近似划分的乳腺癌亚型与保乳治疗后的局部和远处复发相关。
J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14.
9
Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.激素受体和 HER-2 状态可作为乳腺癌分子亚型的替代指标,预测接受保乳治疗的淋巴结阴性亚洲患者的疾病控制情况。
Ann Acad Med Singap. 2011 Feb;40(2):90-6.
10
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.浸润性乳腺癌的基底亚型与常规保乳治疗后真正复发的风险增加相关。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1185-91. doi: 10.1016/j.ijrobp.2011.02.061. Epub 2011 May 19.

引用本文的文献

1
Musashi expression in intestinal stem cells attenuates radiation-induced decline in intestinal permeability and survival in Drosophila.肌球蛋白在肠道干细胞中的表达可减轻辐射诱导的果蝇肠道通透性下降和生存能力下降。
Sci Rep. 2020 Nov 5;10(1):19080. doi: 10.1038/s41598-020-75867-z.
2
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.外照射放疗局限性前列腺癌后胃肠道毒性的多变量正态组织并发症概率模型。
Radiat Oncol. 2013 Sep 23;8:221. doi: 10.1186/1748-717X-8-221.

本文引用的文献

1
Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.保乳治疗早期乳腺癌中乳腺癌亚型对乳腺癌特异性生存、远处转移和局部复发率的预后价值:一项回顾性临床研究。
Eur J Surg Oncol. 2011 Oct;37(10):876-82. doi: 10.1016/j.ejso.2011.07.001. Epub 2011 Aug 6.
2
Recommendation to revise the AJCC/UICC breast cancer staging system for inclusion of proven prognostic factors: ER/PR receptor status and HER2 neu.
Clin Breast Cancer. 2011 Oct;11(5):346-7. doi: 10.1016/j.clbc.2011.05.003. Epub 2011 Aug 5.
3
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.双侧原发性乳腺癌的预后:分期、年龄和两次诊断间隔时间的重要性。
Breast Cancer Res Treat. 2011 Nov;130(2):609-18. doi: 10.1007/s10549-011-1618-8. Epub 2011 Jun 14.
4
Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.浸润性乳腺癌的基底亚型与常规保乳治疗后真正复发的风险增加相关。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1185-91. doi: 10.1016/j.ijrobp.2011.02.061. Epub 2011 May 19.
5
Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.BRCA1 和 BRCA2 基因突变携带者对侧乳腺癌的预测因素。
Br J Cancer. 2011 Apr 26;104(9):1384-92. doi: 10.1038/bjc.2011.120. Epub 2011 Apr 12.
6
The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy.三阴性乳腺癌对保乳治疗后结局的负面影响。
Ann Surg Oncol. 2011 Oct;18(10):2858-65. doi: 10.1245/s10434-011-1669-4. Epub 2011 Mar 26.
7
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.三阴性乳腺癌中未选择患者的 BRCA 突变发生率和结局。
Clin Cancer Res. 2011 Mar 1;17(5):1082-9. doi: 10.1158/1078-0432.CCR-10-2560. Epub 2011 Jan 13.
8
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.利用临床变量和数百个基因表达特征为乳腺癌患者建立预后模型。
BMC Med Genomics. 2011 Jan 9;4:3. doi: 10.1186/1755-8794-4-3.
9
Tailored follow-up for early breast cancer patients: a prognostic index that predicts locoregional recurrence.针对早期乳腺癌患者的个体化随访:预测局部区域复发的预后指数。
Eur J Surg Oncol. 2010 Jul;36(7):617-24. doi: 10.1016/j.ejso.2010.05.010. Epub 2010 Jun 16.
10
Supervised risk predictor of breast cancer based on intrinsic subtypes.基于内在亚型的乳腺癌监督风险预测器
J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9.